GVAX pancreatic tumor cell vaccine
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GVAX pancreatic tumor cell vaccine, covering 2024-08-14 to 2024-08-14. Get the full timeline:
Most recent: Clinical Trial Update: Pancreatic Tumor Cell Vaccine (GVAX), Cyclophosphamide, SBRT, and FOLFIRINOX in Patients With Resected Adenocarcinoma of the Pancreas [Phase 2]